IDH2 and myeloid leukemia: First, shRNA was used to specifically knock down IDH2 expression in two myeloid leukemia lines (U937 and ML-1) that harbor wild-type IDH2 gene (Additional file 3: Fig. S1d) and then examined the impact of decreased IDH2 expression on AML cells survival and proliferation.